MedTrace Logo

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

NCT00288587 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2012-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the ability of Ultrafiltration to influence the rate of hemodynamic improvement, as measured by the decline in the pulmonary artery occlusion pressure, in patients with NYHA class III/IV Heart Failure.

Conditions

Interventions

DRUG

IV loop diuretic

Use of conventional diuretic therapy upon hospital admission for treatment of decompensated heart failure.

DEVICE

NxStage System One

Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.

Sponsors & Collaborators

  • NxStage Medical

    lead OTHER

Principal Investigators

  • Alan Hull, MD · NxStage Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2008-09-30
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288587 on ClinicalTrials.gov